Page 110 - GTM-2-1

Global Translational Medicine GalNAc AGT ASO reduce atherosclerosis

https://doi.org/10.1371/journal.pone.0182566 25. Wu CH, Wu C, Howatt DA, et al., 2020, Two amino
acids proximate to the renin cleavage site of human
19. Tao XR, Rong JB, Lu HS, et al., 2019, Angiotensinogen angiotensinogen do not affect blood pressure and
in hepatocytes contributes to Western diet-induced liver atherosclerosis in mice. Arterioscler Thromb Vasc Biol,
steatosis. J Lipid Res, 60: 1983–1995.
40: 2108–2113.
https://doi.org/10.1194/jlr.M093252
https://doi.org/10.1161/ATVBAHA.120.314048
20. Lu Z, Li Y, Li AJ, et al., 2022, Loss of GPR40 in LDL 26. Kukida M, Cai L, Ye D, et al., 2021, Renal angiotensinogen
receptor-deficient mice exacerbates high-fat diet-induced is predominantly liver derived in nonhuman primates.
hyperlipidemia and nonalcoholic steatohepatitis. PLoS One, Arterioscler Thromb Vasc Biol, 41: 2851–2853.
17: e0277251.
https://doi.org/10.1161/ATVBAHA.121.316590
https://doi.org/10.1371/journal.pone.0277251
27. Wang CH, Liu HM, Chang ZY, et al., 2021, Losartan
21. Liu Y, Zhang Y, Zhu H, et al., 2022, Aucubin administration prevents hepatic steatosis and macrophage polarization by
suppresses STING signaling and mitigated high-fat diet- inhibiting HIF-1α in a murine model of NAFLD. Int J Mol
induced atherosclerosis and steatohepatosis in LDL receptor Sci, 22: 7841.
deficient mice. Food Chem Toxicol, 169: 113422.
https://doi.org/10.3390/ijms22157841
https://doi.org/10.1016/j.fct.2022.113422
28. Stucchi P, Cano V, Ruiz-Gayo M, et al., 2009, Aliskiren
22. de Jong LM, Zhang Z, den Hartog Y, et al., 2022, PRMT3 reduces body-weight gain, adiposity and plasma leptin
inhibitor SGC707 reduces triglyceride levels and induces during diet-induced obesity. Br J Pharmacol, 158: 771–778.
pruritus in Western-type diet-fed LDL receptor knockout
mice. Sci Rep, 12: 483. https://doi.org/10.1111/j.1476-5381.2009.00355.x
https://doi.org/10.1038/s41598-021-04524-w 29. Premaratna SD, Manickam E, Begg DP, et al., 2012,
Angiotensin-converting enzyme inhibition reverses diet-
23. Lu H, Cassis LA, Daugherty A, 2007, Atherosclerosis induced obesity, insulin resistance and inflammation in
and arterial blood pressure in mice. Curr Drug Targets, 8: C57BL/6J mice. Int J Obes (Lond), 36: 233–243.
1181–1189.
https://doi.org/10.1038/ijo.2011.95
https://doi.org/10.2174/138945007782403829
30. Cruz-López EO, Ren L, Uijl E, et al., 2023, Blood pressure-
24. Wu C, Xu Y, Lu H, et al., 2015, Cys18-Cys137 disulfide bond independent renoprotective effects of small interference
in mouse angiotensinogen does not affect AngII-dependent RNA targeting liver angiotensinogen in experimental
functions in vivo. Hypertension, 65: 800–805. diabetes. Br J Pharmacol, 180: 80–93.
https://doi.org/10.1161/HYPERTENSIONAHA.115.05166 https://doi.org/10.1111/bph.15955

Volume 2 Issue 1 (2023) 10 https://doi.org/10.36922/gtm.288